PACS Group (NYSE:PACS) CEO Sells $1,107,470.52 in Stock

Posted by Joseph Griffin on Oct 8th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 26,052 shares of the stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $42.51, for a total transaction of $1,107,470.52. Following the sale, the chief executive officer owned 54,496,165 shares in the company, valued at approximately $2,316,631,974.15. This trade represents a 0.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total value of $30,458.16.
On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total value of $1,550,162.75.
On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total value of $1,033,395.84.
On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total value of $1,358,606.16.
On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The stock was sold at an average price of $45.03, for a total value of $14,274.51.
On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total value of $476,226.67.
On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total value of $396,098.36.
On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total value of $206,164.14.
On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total value of $1,046,238.93.
On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total value of $984,943.68.

PACS Group Stock Performance

PACS stock opened at $43.02 on Thursday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market capitalization of $6.81 billion, a price-to-earnings ratio of 25.01, a PEG ratio of 1.34 and a beta of -0.08. PACS Group, Inc. has a 1 year low of $10.31 and a 1 year high of $49.49. The stock’s fifty day moving average is $43.74 and its two-hundred day moving average is $39.87.

PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. On average, research analysts predict that PACS Group, Inc. will post 2.13 EPS for the current year.

Analyst Ratings Changes

A number of research firms have issued reports on PACS. Weiss Ratings lowered shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, August 5th. JPMorgan Chase & Co. raised their price target on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Oppenheimer lifted their price target on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Truist Financial set a $62.00 price objective on PACS Group in a research report on Wednesday, September 2nd. Finally, Royal Bank Of Canada increased their price objective on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a report on Thursday, August 6th. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $58.80.

View Our Latest Research Report on PACS

Institutional Investors Weigh In On PACS Group

Several institutional investors have recently bought and sold shares of PACS. Financial Management Professionals Inc. grew its position in PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after buying an additional 235 shares in the last quarter. Jacobsen Capital Management raised its position in shares of PACS Group by 1.6% during the 1st quarter. Jacobsen Capital Management now owns 18,128 shares of the company’s stock worth $582,000 after buying an additional 294 shares in the last quarter. Strategic Advocates LLC raised its position in shares of PACS Group by 18.5% during the 4th quarter. Strategic Advocates LLC now owns 5,182 shares of the company’s stock worth $203,000 after buying an additional 808 shares in the last quarter. Peterson Wealth Services raised its position in shares of PACS Group by 1.6% during the 1st quarter. Peterson Wealth Services now owns 53,672 shares of the company’s stock worth $1,724,000 after buying an additional 854 shares in the last quarter. Finally, Swiss National Bank lifted its stake in shares of PACS Group by 1.3% in the 1st quarter. Swiss National Bank now owns 93,000 shares of the company’s stock worth $2,987,000 after acquiring an additional 1,200 shares during the period.

About PACS Group

(Get Free Report)

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.